To further validate whether lovastatin enhances sensitivity to radiotherapy in a colon cancer xenograft model through the activation of cGAS–STING in vivo, we detected a substantial increase in the expression of genes associated with the cGAS–STING signaling pathway in the combination therapy group compared with the radiotherapy group (Fig. 7c). This evidence concerns the gene STING1 and malignant colon neoplasm.